CD14 / Janelia Fluor 646 / atibuclimab

Product Details
Supplier Novus Biologicals, a Bio-Techne brand
Catalog #: NBP3-28217JF646 (View supplier product page)
Size 100 μl
Price $379.00
Antigen CD14
Clone atibuclimab
Host Human
Isotype IgG4
Conjugate Janelia Fluor 646
Target Species Human
Applications FC, ELISA, Functional
Description CD14 Antibody (atibuclimab) [Janelia Fluor® 646]
About CD14 and Janelia Fluor 646
CD14 The protein encoded by this gene is a surface antigen that is preferentially expressed on monocytes/macrophages. It cooperates with other proteins to mediate the innate immune response to bacterial lipopolysaccharide, and to viruses. This gene has been identified as a target candidate in the treatment of SARS-CoV-2-infected patients to potentially lessen or inhibit a severe inflammatory response. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Aug 2020]
Janelia Fluor 646 Janelia Fluor® 646 was developed at the Janelia Campus of the Howard Hughes Medical Institute but is commercialized by other vendors. The Janelia Fluor®s family is unique in that the fluorophores are cell-permeable and are available in photoactivatable forms. These fluorophores were developed for super-resolution microscopy (STED, PALM and STORM) and live-cell microscopy in the HaloTag and SNAP-tag versions. Janelia Fluor® 646 has an excitation peak at 646 nm and an emission peak at 664 nm.
Citations
Additional
Sources
Reviews & Ratings
Submit a Review

Janelia Fluor 646 Excitation and Emission Spectra